MabVax Therapeutics Holdings, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware on March 21, 2019. The debtor listed its assets in the range of less than $0.05 million and liabilities in the range of $1 million to $10 million. The debtor is represented by Jason A. Gibson and Frederick Brian Rosner of The Rosner Law Group LLC as its legal counsels and Baker Botts L.L.P. and Block & Leviton LLP as its special litigation counsels.